Figure 3.
Integrin β1 (ITGB1) inhibition enhances the effect of bevacizumab treatment on cell apoptosis. (A and B) MTT analysis. (C) Flow cytometric assay. Data are presented as the mean ± standard deviation of duplicates from a representative experiment performed in triplicate. *P<0.01, vs. the control (Con) and lentiviral vector (LV)-negative control (NC) groups. **P<0.01, vs. the LV-ITGB1 and bevacizumab-treated (Beva) groups.